229 related articles for article (PubMed ID: 26985708)
1. Curcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells.
Zhang Z; Chen H; Xu C; Song L; Huang L; Lai Y; Wang Y; Chen H; Gu D; Ren L; Yao Q
Oncol Rep; 2016 May; 35(5):2615-23. PubMed ID: 26985708
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
3. Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress.
Lu Y; Zhang R; Zhang X; Zhang B; Yao Q
Biomed Pharmacother; 2020 Sep; 129():110381. PubMed ID: 32887024
[TBL] [Abstract][Full Text] [Related]
4. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
6. miR-130b targets NKD2 and regulates the Wnt signaling to promote proliferation and inhibit apoptosis in osteosarcoma cells.
Li Z; Li Y; Wang N; Yang L; Zhao W; Zeng X
Biochem Biophys Res Commun; 2016 Mar; 471(4):479-85. PubMed ID: 26902120
[TBL] [Abstract][Full Text] [Related]
7. Antrodia camphorata inhibits metastasis and epithelial-to-mesenchymal transition via the modulation of claudin-1 and Wnt/β-catenin signaling pathways in human colon cancer cells.
Hseu YC; Chao YH; Lin KY; Way TD; Lin HY; Thiyagarajan V; Yang HL
J Ethnopharmacol; 2017 Aug; 208():72-83. PubMed ID: 28688953
[TBL] [Abstract][Full Text] [Related]
8. Curcumin decreases epithelial‑mesenchymal transition by a Pirin‑dependent mechanism in cervical cancer cells.
Aedo-Aguilera V; Carrillo-Beltrán D; Calaf GM; Muñoz JP; Guerrero N; Osorio JC; Tapia JC; León O; Contreras HR; Aguayo F
Oncol Rep; 2019 Nov; 42(5):2139-2148. PubMed ID: 31436299
[TBL] [Abstract][Full Text] [Related]
9. SDF‑1/CXCR4 induces epithelial‑mesenchymal transition through activation of the Wnt/β‑catenin signaling pathway in rat chronic allograft nephropathy.
Tang H; Xu Y; Zhang Z; Zeng S; Dong W; Jiao W; Hu X
Mol Med Rep; 2019 May; 19(5):3696-3706. PubMed ID: 30896799
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines.
Gallardo M; Calaf GM
Int J Oncol; 2016 Sep; 49(3):1019-27. PubMed ID: 27573203
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Inhibits Cell Viability and Increases Apoptosis of SW620 Human Colon Adenocarcinoma Cells via the Caudal Type Homeobox-2 (CDX2)/Wnt/β-Catenin Pathway.
Jiang X; Li S; Qiu X; Cong J; Zhou J; Miu W
Med Sci Monit; 2019 Oct; 25():7451-7458. PubMed ID: 31584928
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
[TBL] [Abstract][Full Text] [Related]
13. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
14. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial-mesenchymal transition.
Zhang C; Xu Y; Wang H; Li G; Yan H; Fei Z; Xu Y; Li W
Anticancer Drugs; 2018 Apr; 29(4):334-340. PubMed ID: 29420338
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells.
Kishore C; Sundaram S; Karunagaran D
Chem Biol Interact; 2019 Aug; 309():108725. PubMed ID: 31238027
[TBL] [Abstract][Full Text] [Related]
16. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
[TBL] [Abstract][Full Text] [Related]
17. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling.
Du Y; Long Q; Zhang L; Shi Y; Liu X; Li X; Guan B; Tian Y; Wang X; Li L; He D
Int J Oncol; 2015 Dec; 47(6):2064-72. PubMed ID: 26499200
[TBL] [Abstract][Full Text] [Related]
19. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells.
Huang T; Chen Z; Fang L
Oncol Rep; 2013 Jan; 29(1):117-24. PubMed ID: 23076367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]